Mirtazapina Zentiva (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Zentiva, is a NaSSA presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients.

GNH USA supplies Mirtazapina Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is used within the antidepressant therapeutic pathway to manage depressive disorders. - Major depressive disorder (acute phase): reduces depressive symptoms and improves mood. - Major depressive disorder (maintenance): helps prevent relapse after initial response. - Major depressive disorder with insomnia: promotes sleep and alleviates associated fatigue.

Mirtazapine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Sedation: drowsiness or feeling unusually sleepy. - Increased appetite and weight gain: noticeable rise in food intake and body weight. - Dry mouth: reduced salivation leading to oral discomfort. - Constipation: infrequent bowel movements or difficulty passing stool. - Dizziness: sensation of light‑headedness, especially when standing.

Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells requiring immediate medical attention. - Severe hypersensitivity reactions: rash, swelling, or anaphylaxis. - Suicidal thoughts or behavior: emergence or worsening of suicidal ideation. - Serotonin syndrome: confusion, rapid heart rate, and high fever when combined with other serotonergic agents. - Hepatic dysfunction: abnormal liver enzymes indicating potential liver injury.

Before initiating therapy with Mirtazapine, several precautionary measures should be considered. - Psychiatric assessment: monitor for worsening depression or emergence of suicidal thoughts. - Hepatic function: evaluate liver status and adjust use in severe impairment. - Renal function: assess kidney health, especially in patients with severe renal disease. - Discontinuation: avoid abrupt stopping; taper the dose under medical supervision. - Pregnancy and lactation: prescribe only if potential benefits outweigh potential risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Mirtazapine can interact with other medicines, influencing its safety and effectiveness.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome. - Linezolid or other serotonergic antibiotics: potential for serotonin syndrome. - Potent CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine plasma concentrations.

Moderate Interactions (Monitor Closely): - Central nervous system depressants (alcohol, benzodiazepines): additive sedation. - Anticholinergic agents (e.g., diphenhydramine): increased dry mouth and constipation. - Other antidepressants (SSRIs, SNRIs): monitor for enhanced serotonergic effects.